Ingemar L.
- Country
- Sweden
- Department
- Department of Haematology
Research Overview
- Phase II Study of ME-401 with Rituximab-Bendamustine for High-Risk and Rituximab with ME-401 Randomization for Low-Risk Follicular Lymphoma Treatment
- Randomized European Trial of Autologous Transplantation with Rituximab, Ibrutinib, and Ara-C Induction in Generalized Mantle Cell Lymphoma
- Phase 3 Randomized Trial of Bortezomib, Lenalidomide, Dexamethasone, and Ciltacabtagene Autoleucel in Newly Diagnosed Multiple Myeloma Without Planned Stem Cell Transplant
Data & Insights
Has run more than one trial at 176 of 409 partner sites.
Specializations
Lymphoma Research
The investigator specializes in various forms of lymphoma, with particular focus on follicular lymphoma and diffuse large B-cell lymphoma (DLBCL). Their research encompasses innovative therapeutic approaches combining established and novel treatments.
- Advanced Follicular Lymphoma Therapies
- DLBCL Treatment Optimization
- Mantle Cell Lymphoma Management
- Hodgkin Lymphoma Interventions
The investigator explores combination therapies involving rituximab-based regimens and novel agents for lymphoma treatment.
Multiple Myeloma Studies
Research activities include investigation of multiple myeloma treatments, particularly focusing on patients ineligible for stem cell transplantation as initial therapy. The work involves evaluation of combination therapeutic approaches.
- Novel Therapeutic Combinations
- Non-Transplant Treatment Strategies
- Progressive Disease Management
The research emphasizes optimizing treatment outcomes for newly diagnosed multiple myeloma patients.
Innovative Treatment Approaches
The investigator focuses on developing and evaluating targeted therapeutic strategies across various hematologic malignancies. Their work includes assessment of novel drug combinations and treatment sequences.
- Combination Therapy Development
- Treatment Response Assessment
- Progressive Disease Interventions
Research encompasses evaluation of progression-free survival and treatment efficacy in various hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.